Bank of Montreal’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-6,474
| Closed | -$57.8K | – | 3880 |
|
|
2023
Q4 | $57.8K | Sell |
6,474
-2,036
| -24% | -$18.2K | ﹤0.01% | 3098 |
|
|
2023
Q3 | $153K | Sell |
8,510
-34,567
| -80% | -$621K | ﹤0.01% | 2744 |
|
|
2023
Q2 | $1.27M | Sell |
43,077
-3,443
| -7% | -$101K | ﹤0.01% | 1756 |
|
|
2023
Q1 | $1.52M | Buy |
+46,520
| New | +$1.52M | ﹤0.01% | 1622 |
|
|
2021
Q3 | – | Sell |
-19,385
| Closed | -$617K | – | 3702 |
|
|
2021
Q2 | $617K | Sell |
19,385
-1,768
| -8% | -$56.3K | ﹤0.01% | 2599 |
|
|
2021
Q1 | $586K | Sell |
21,153
-9,381
| -31% | -$260K | ﹤0.01% | 2216 |
|
|
2020
Q4 | $884K | Buy |
30,534
+6,830
| +29% | +$198K | ﹤0.01% | 1964 |
|
|
2020
Q3 | $604K | Sell |
23,704
-1,414
| -6% | -$36K | ﹤0.01% | 1916 |
|
|
2020
Q2 | $637K | Buy |
25,118
+4,704
| +23% | +$119K | ﹤0.01% | 1841 |
|
|
2020
Q1 | $279K | Buy |
20,414
+246
| +1% | +$3.36K | ﹤0.01% | 1980 |
|
|
2019
Q4 | $327K | Buy |
20,168
+10,142
| +101% | +$164K | ﹤0.01% | 2437 |
|
|
2019
Q3 | $130K | Sell |
10,026
-275
| -3% | -$3.57K | ﹤0.01% | 2700 |
|
|
2019
Q2 | $134K | Buy |
10,301
+7,059
| +218% | +$91.8K | ﹤0.01% | 2724 |
|
|
2019
Q1 | $51K | Sell |
3,242
-223
| -6% | -$3.51K | ﹤0.01% | 2941 |
|
|
2018
Q4 | $69K | Buy |
3,465
+238
| +7% | +$4.74K | ﹤0.01% | 2821 |
|
|
2018
Q3 | $81K | Buy |
3,227
+2,994
| +1,285% | +$75.2K | ﹤0.01% | 2891 |
|
|
2018
Q2 | $6K | Buy |
+233
| New | +$6K | ﹤0.01% | 3757 |
|
|
2016
Q1 | – | Sell |
-73
| Closed | -$2K | – | 4067 |
|
|
2015
Q4 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 3762 |
|
|
2014
Q3 | – | Sell |
-170
| Closed | -$6K | – | 3926 |
|
|
2014
Q2 | $6K | Buy |
+170
| New | +$6K | ﹤0.01% | 3689 |
|